Chandigarh: Health Team Inspects Chemist Shops At GMSH-16 After Garg’s Visit

Chandigarh : Two days after UT health secretary Yashpal Garg found irregularities at chemist shops in the Government Multi-Specialty Hospital, Sector 16, a drug inspection team from UT health department conducted a “weekly inspection” at these shops.

Garg noted that the chemists were still generating bills only on specific demand and selling medicines without bills.

When questioned about the recent episode with the health secretary, one of the chemist shop owners claimed that they were simply dispensing the medicine as per the doctor’s prescription.

After an inspection on Saturday, Garg had instructed a health department drug inspector to investigate the relationship between a manufacturer of a syrup named “MCAIN” and a chemist at GMSH-16. He noted that one of the three chemist shops had stocked a syrup which was significantly costlier than the alternatives available the remaining two shops.

Notably, the health secretary, donning a kurta-pyjama with a scarf around his neck to avoid identification, inspected the hospital and observed that out of the three chemist shops located on its premises, only one had stocked the syrup, which was considerably more expensive than the alternatives available at the other two shops.

Garg said complaints had been received, alleging that certain doctors were promoting specific chemist shops, drug brands and labs. Without disclosing any names, he said appropriate action will be taken if the allegations were found true.

The inspection team, meanwhile, denied any connection between the routine check and the recent inspection by the health secretary.

  • Related Posts

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’